SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-037398
Filing Date
2019-06-17
Accepted
2019-06-17 16:34:31
Documents
2
Period of Report
2019-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2169
2 POA DOCUMENT poa.txt EX-24.3_860425 4097
  Complete submission text file 0001209191-19-037398.txt   7784
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Issuer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AASTROM BIOSCIENCES, INC. 24 FRANK LLOYD WRIGHT DRIVE ANN ARBOR MI 48105
Business Address
Hagen Heidi (Reporting) CIK: 0001585084 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33038 | Film No.: 19901735